Brevan Howard Capital Management’s Caribou Biosciences CRBU Stock Holding History

Brevan Howard Capital Management’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$124K	Buy	+65,062	New	+$112K	﹤0.01%	1991
2025 Q3	–	Sell	-155,521	Closed	-$196K	–	1989
2025 Q2	$196K	Buy	+155,521	New	+$153K	﹤0.01%	1714
2024 Q3	–	Sell	-77,121	Closed	-$126K	–	1185
2024 Q2	$126K	Buy	77,121 +66,867	+652%	+$214K	﹤0.01%	949
2024 Q1	$52.7K	Buy	+10,254	New	+$63.2K	﹤0.01%	935

Other funds holding CRBU

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Brevan Howard Capital Management's CRBU Position: Q1 2026 in Review

Brevan Howard Capital Management opened a new position in Caribou Biosciences (CRBU) in Q1 2026: 65,062 shares worth $124K. The stake represents ﹤0.01% of the portfolio and ranks #1991 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in CRBU as recently as Q2 2025.

Brevan Howard Capital Management first reported a position in CRBU in Q1 2024 and has held it in 4 quarters since. The position peaked at $196K in Q2 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

Brevan Howard Capital Management held 65,062 shares of Caribou Biosciences worth $124K as of Q1 2026.
Caribou Biosciences was a new Brevan Howard Capital Management position in Q1 2026.
Caribou Biosciences made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1991 holding.
Brevan Howard Capital Management first reported a position in Caribou Biosciences in Q1 2024 and has held it in 4 quarters since.
Brevan Howard Capital Management's Caribou Biosciences position peaked at $196K in Q2 2025.
137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.